| Old Articles: <Older 48491-48500 Newer> |
|---|
 |
The Motley Fool
May 5, 2011
Gary Cassady |
Retailers Blow Sales Estimates Out of the Water Companies point to several factors in pulling off a successful month.   |
Financial Planning
May 1, 2011
Craig L. Israelsen |
Getting Back In For the most conservative clients, the most prudent way to reenter the equity markets is by degree. For investors with well-diversified portfolios and lengthy holding periods, a lump-sum approach will likely produce better outcomes. |
InternetNews
May 5, 2011
Sean Michael Kerner |
Cisco Reorganizes Its Business Networking giant attempts to stem decline by streamlining its business operations. |
The Motley Fool
May 5, 2011
Matt Koppenheffer |
Deer Consumer Products Shares Plunged: What You Need to Know Shares of Chinese appliance manufacturer Deer Consumer Products took a beating today, falling by as much as 14% in intraday trading on light volume. |
The Motley Fool
May 5, 2011
Anders Bylund |
Leap Wireless International Shares Popped: What You Need to Know Shares of Leap Wireless International lived up to their name today, having jumped as high as 15% on extremely heavy trading volume. |
The Motley Fool
May 5, 2011
Tim Beyers |
H&E Equipment Services Shares Plunged: What You Need to Know Two months after surging on surprisingly strong fourth-quarter results, industrial-equipment renter H&E Equipment Services saw its shares fall as much as 11% this morning after reporting worse-than-expected Q1 financials. |
The Motley Fool
May 5, 2011
Anders Bylund |
Rofin-Sinar Technologies Shares Plunged: What You Need to Know Shares of laser technologist Rofin-Sinar Technologies are looking dim today, falling as much as 14.1% on heavy volume before recovering to a drop about half that drastic. |
The Motley Fool
May 4, 2011
Arunava De |
Can Barnes & Noble Get its Footing in the Battle of the Books? The story of the Barnes & Noble e-book reader has reached a gloomy chapter. |
The Motley Fool
May 4, 2011
Brian Orelli |
For Pfizer, Breaking Up Is Hard to Do CEO Ian Read pushes back the decision on the company's breakup until 2012. |
Chemistry World
May 4, 2011
Andrew Turley |
Teva sidelines Valeant with $6.8bn Cephalon bid US drugmaker Cephalon has agreed to a $6.8 billion ( 4.1 billion) takeover bid from Israeli generics manufacturer Teva, which has beaten into second place Canadian pharma company Valeant. |
| <Older 48491-48500 Newer> Return to current articles. |
